The Moving Average Convergence Divergence (MACD) for ADGM turned positive on October 13, 2026. Looking at past instances where ADGM's MACD turned positive, the stock continued to rise in 17 of 19 cases over the following month. The odds of a continued upward trend are 89%.
The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 22 of 27 cases where ADGM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 81%.
Following a +22.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where ADGM advanced for three days, in 77 of 90 cases, the price rose further within the following month. The odds of a continued upward trend are 86%.
ADGM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ADGM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ADGM entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 34 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-5.930) is normal, around the industry mean (2.874). P/E Ratio (-0.081) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (60.976) is also within normal values, averaging (40.124).
The Tickeron Price Growth Rating for this company is 98 (best 1 - 100 worst), indicating slightly worse than average price growth. ADGM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ADGM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where INFU advanced for three days, in 173 of 262 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
The Moving Average Convergence Divergence (MACD) for INFU just turned positive on October 20, 2026. Looking at past instances where INFU's MACD turned positive, the stock continued to rise in 38 of 61 cases over the following month. The odds of a continued upward trend are 62%.
The Aroon Indicator entered an Uptrend today. In 88 of 138 cases where INFU Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 64%.
The 10-day RSI Indicator for INFU moved out of overbought territory on October 21, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 23 similar instances where the indicator moved out of overbought territory. In 20 of the 23 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where INFU declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.
INFU broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. INFU’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 56 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 62 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.731) is normal, around the industry mean (2.874). P/E Ratio (33.452) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.180) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.817) is also within normal values, averaging (40.124).
The Tickeron Profit vs. Risk Rating rating for this company is 92 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INFU’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.
INFU | ||
|---|---|---|
OUTLOOK RATING 1..100 | 37 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 81 Overvalued | |
PROFIT vs RISK RATING 1..100 | 92 | |
SMR RATING 1..100 | 56 | |
PRICE GROWTH RATING 1..100 | 36 | |
P/E GROWTH RATING 1..100 | 62 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| ADGM | INFU | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 88% | 1 day ago 87% |
| Stochastic ODDS (%) | 1 day ago 81% | 1 day ago 79% |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | 1 day ago 89% | 1 day ago 62% |
| TrendWeek ODDS (%) | 1 day ago 88% | 1 day ago 69% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 74% |
| Advances ODDS (%) | 3 days ago 86% | 3 days ago 66% |
| Declines ODDS (%) | 1 day ago 90% | 22 days ago 79% |
| BollingerBands ODDS (%) | 1 day ago 85% | 1 day ago 86% |
| Aroon ODDS (%) | 1 day ago 89% | 1 day ago 64% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ADGM’s FA Score shows that 1 FA rating(s) are green while INFU’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ADGM’s TA Score shows that 5 TA indicator(s) are bullish while INFU’s TA Score has 3 bullish TA indicator(s).
ADGM (@Medical/Nursing Services) experienced а +29.55% price change this week, while INFU (@Medical/Nursing Services) price change was +3.31% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.
ADGM is expected to report earnings on Nov 11, 2026.
INFU is expected to report earnings on Nov 03, 2026.
The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
A.I.dvisor indicates that over the last year, ADGM has been loosely correlated with AMIX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ADGM jumps, then AMIX could also see price increases.
| Ticker / NAME | Correlation To ADGM | 1D Price Change % | ||
|---|---|---|---|---|
| ADGM | 100% | -3.90% | ||
| AMIX - ADGM | 38% Loosely correlated | -2.72% | ||
| INFU - ADGM | 24% Poorly correlated | +0.64% | ||
| NNOX - ADGM | 23% Poorly correlated | -0.36% | ||
| BMRA - ADGM | 23% Poorly correlated | N/A | ||
| CLPT - ADGM | 22% Poorly correlated | N/A | ||
More | ||||
A.I.dvisor indicates that over the last year, INFU has been loosely correlated with AMIX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if INFU jumps, then AMIX could also see price increases.
| Ticker / NAME | Correlation To INFU | 1D Price Change % | ||
|---|---|---|---|---|
| INFU | 100% | +0.64% | ||
| AMIX - INFU | 43% Loosely correlated | -2.72% | ||
| VREX - INFU | 42% Loosely correlated | -0.05% | ||
| ICUI - INFU | 39% Loosely correlated | +4.66% | ||
| BFLY - INFU | 38% Loosely correlated | -4.08% | ||
| ANIK - INFU | 33% Loosely correlated | +2.38% | ||
More | ||||